HURA insider filings
TuHURA Biosciences, Inc./NV — 18 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen HURA transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Bianco James A. — Chief Executive Officer, Director | 1 | — | — | 1 |
Recent insider filings — TuHURA Biosciences, Inc./NV
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Bianco James A. — Chief Executive Officer, Director | Gift (G): 75,000 @ $0 | EDGAR |
| 2026-05-29 | 4 | Bianco James A. — Chief Executive Officer, Director | Gift (G): 150,000 @ $0 | EDGAR |
| 2026-02-17 | 4 | Tendler Craig — Director | Grant/award (A): 156,240 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Ng George K — Director | Grant/award (A): 156,240 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | List Alan — Director | Grant/award (A): 156,240 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 156,240 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Hoffman Robert E. — Director | Grant/award (A): 156,240 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | Dearborn Dan — Chief Financial Officer | Grant/award (A): 273,696 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | Bianco James A. — Chief Executive Officer, Director | Grant/award (A): 610,332 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Dearborn Dan — Chief Financial Officer | Grant/award (A): 1,531,367 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Bianco James A. — Chief Executive Officer, Director | Grant/award (A): 3,414,891 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Tendler Craig — Director | Grant/award (A): 151,883 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Ng George K — Director | Grant/award (A): 51,275 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | List Alan — Director | Grant/award (A): 51,275 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | MANUSO JAMES S J — Director | Grant/award (A): 59,590 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Hoffman Robert E. — Director | Grant/award (A): 51,275 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | Dearborn Dan — Chief Financial Officer | Grant/award (A): 489,848 (derivative) @ $0 | EDGAR |
| 2024-11-14 | 4 | Bianco James A. — Chief Executive Officer, Director | Grant/award (A): 1,065,990 (derivative) @ $0 | EDGAR |
Recent 8-K events — TuHURA Biosciences, Inc./NV
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-18 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-06 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-16 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-24 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-17 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-17 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-04 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-21 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HURA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs